The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C. Townsend, Michelle A. Kelliher, Mark A. Murakami et al.|Cancer Cell|2016Cited by 304
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Muxin Gu et al.|Blood|2022Cited by 100
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C. Townsend, Michelle A. Kelliher, Mark A. Murakami et al.|Cancer Cell|2016Cited by 78
Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosisHarald Ehrhardt, Irmela Jeremias|Cell Death and Disease|2013Cited by 45
Optimized anti–tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application scheduleHarald Ehrhardt, Irmela Jeremias|Blood|2011Cited by 32